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NC-ND license (http://creativecommoSummary This review describes the recent advances in, and current status of, minimally
invasive pancreatic surgery (MIPS). Typical MIPS procedures are laparoscopic pancreaticoduo-
denectomy (LPD), laparoscopic distal pancreatectomy (LDP), laparoscopic central pancreatec-
tomy (LCP), and laparoscopic total pancreatectomy (LTP). Some retrospective studies
comparing LPD or LDP and open procedures have demonstrated the safety and feasibility as
well as the intraoperative outcomes and postoperative recovery of these procedures. In
contrast, LCP and LTP have not been widely accepted as common laparoscopic procedures
owing to their complicated reconstruction and limited indications. Nevertheless, our concise
review reveals that LCP and LTP performed by expert laparoscopic surgeons can result in good
short-term and long-term outcomes. Moreover, as surgeons’ experience with laparoscopic
techniques continues to grow around the world, new innovations and breakthroughs in MIPS
will evolve. Well-designed and suitably powered randomized controlled trials of LPD, LDP,
LCP, and LTP are now warranted to demonstrate the superiority of these procedures.
Copyright ª 2016, Asian Surgical Association. Published by Elsevier Taiwan LLC. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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+ MODELwith that of other abdominal procedures.1 As surgeons
become more adept at advanced laparoscopic procedures,
there is increasing evidence demonstrating not only the
safety and feasibility of MIPS, but also the significant ad-
vantages in postoperative recovery and the long-term sur-
vival rate, which is equivalent to that of open pancreatic
resection.2
In this paper, we have reviewed recent advances in MIPS
procedures, such as laparoscopic pancreaticoduo-
denectomy (LPD), laparoscopic distal pancreatectomy
(LDP), laparoscopic central pancreatectomy (LCP), and
laparoscopic total pancreatectomy (LTP). Since some
recent articles have already reviewed LPD and LDP in
detail, we have summarized the current status of LPD and
LDP and examined LCP and LTP more precisely.
2. Methods
2.1. Definitions of each surgical procedure
We examined LPD, LDP, LCP, and LTP for pancreatobiliary
diseases using laparoscopic procedures. Each reconstruc-
tion had to be performed intracorporeally under pneumo-
peritoneum to satisfy the determination of a totally
laparoscopic procedure. We provided an overview of each
procedure and described the associated indications,
intraoperative outcomes, postoperative outcomes, and
oncologic outcomes. In addition, we assessed meta-
analyses of LPD and LDP and conducted the first litera-
ture review of LTP.
2.2. Search strategy
This review included only English articles identified by the
terms “laparoscopic pancreaticoduodenectomy,” “laparo-
scopic distal pancreatectomy,” “laparoscopic central
pancreatectomy,” or “laparoscopic total pancreatectomy”
in the PubMed online database. On March 20, 2016, a final
search of PubMed was performed, and we selected meta-
analyses of LPD and LDP. To date, there have been no meta-
analyses for LCP and LTP; therefore, we selected all the
existing case reports and literature reviews.
2.3. Analysis of each surgical procedure
We collected and analyzed meta-analyses of LPD and LDP.
We also summarized the case reports and literature reviews
relating to LCP and LTP.
3. Results
3.1. LPD
3.1.1. Overview of LPD
Pancreaticoduodenectomy is a curative surgical procedure
for hepatobiliary and pancreatic neoplasms and is highly
demanding, even in the hands of skilled surgeons with spe-
cific training.3,4 Gagner and Pomp5 first reported regarding
LPD in 1994; however, the acceptance of LPD was consid-
erably slowed by both the inherent technical limitations ofPlease cite this article in press as: Umemura A, et al., Current status
Asian Journal of Surgery (2016), http://dx.doi.org/10.1016/j.asjsur.20laparoscopic procedures and the need for surgeons to learn
advanced laparoscopic techniques. Recent advances in
laparoscopic procedures, technological innovations, and
surgeons’ passion to pursue LPD have all contributed to the
increased popularity and acceptance of LPD. As of 2015, 746
patients had undergone LPD globally, and in over 50% of the
cases, pylorus preservation was used.6
The main problems with LPD compared with open pan-
creaticoduodenectomy (OPD) relate to the intraoperative
outcomes, postoperative outcomes, and oncologic out-
comes. Notwithstanding, although there have been no
randomized controlled trials (RCTs) comparing LPD and
OPD, there are some review articles addressing this com-
parison.4,6 Based on these articles, we present some
notable points about LPD.
3.1.2. Indications for LPD
Apart from the traditional contraindications of laparoscopic
procedures, the contraindications of LPD are patients who
require concomitant vessel reconstruction or anatomical
hepatectomy6 because these cases are presumed to have
high complication and mortality rates; however, there have
been no reports of such a case series. The earliest case
series of LPD involved patients with small, benign, or low-
grade tumors of the pancreatic head, duodenal ampulla,
and distal common bile duct. Recent case series of LPD also
involved typical patients with carcinomas located at the
distal bile duct, the pancreatic head and uncinate process
of the pancreas, and the duodenum and duodenal
ampulla.7,8 Patients with mucinous cystic neoplasms and
intraductal papillary mucinous neoplasms (IPMN) are also
good candidates for LPD.9
3.1.3. Intraoperative outcomes
Complete achievement of LPD is still relatively difficult
owing mainly to tumor adherence and invasion into the
portal vein, unexpected bleeding, obesity, and severe
pancreatitis. The conversion rate to OPD is reported as
9.1%.6 According to a systematic literature review of LPD by
Boggi et al,6 the weighted averages of operative time and
intraoperative blood loss were 464.3 minutes and 320.7 mL,
respectively. Furthermore, another meta-analysis showed
that LPD provides a decrease in intraoperative blood loss
with a mean difference of 361.93 mL.4
3.1.4. Postoperative outcomes
Information on morbidity is a very important outcome of
LPD, and Boggi et al6 reported that the morbidity rate of LPD
was 41.2%. However, the meta-analysis revealed no statis-
tical difference between LPD and OPD, including post-
operative pancreatic fistula (POPF) [odds ratio (OR)Z 0.96,
95% confidence interval (CI)Z 0.65e1.44, pZ 0.86,
I2Z 0%] and delayed gastric emptying (ORZ 0.99, 95%
CIZ 0.62e1.56, pZ 0.96, I2Z 0%).4 The mortality rate in
the literature review was reported as 1.9%,6 and the meta-
analysis also showed that there was no significant statisti-
cal difference in mortality between LPD and OPD
(ORZ 0.82, 95% CIZ 0.37e1.85, pZ 0.64, I2Z 0%).4
With regard to hospital stay, in a recent study comparing
108 LPD and 214 OPD cases well matched for pathologic
parameters, Croome et al10 reported a significantly shorter
length of hospital stay in the LPD group (6 days vs. 9 days,of laparoscopic pancreaticoduodenectomy and pancreatectomy,
16.09.003
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of hospital stay was significantly shorter, by 2.64 days, for
LPD patients.4 Nevertheless, the weighted average for the
length of hospital stay was different depending on the re-
gion: 21.3 days for 143 LPD cases in Europe, 13.0 days for
293 LPD cases in Asia, and 9.4 days for 243 LPD cases in
North America.6 These statistics are incompatible with the
reported incidence of postoperative complications because
postoperative morbidity is over 40%, as stated previously.6
3.1.5. Oncologic outcomes
The rate of negative surgical margin for LPD has been
estimated to be similar to that for OPD, and some reports
achieved a 100% negative surgical margin; hence, the short-
term oncologic outcomes of LPD are almost equivalent to
those of OPD.6,11,12 However, both the published case series
and some reviews about negative surgical margins have
been associated with selection bias; specifically, patients
with major vascular involvement or a large tumor have
undergone OPD. Accordingly, there is still no strong evi-
dence that LPD is superior to OPD with regard to R0
resection.
While LPD is employed for various hepatobiliary and
pancreatic diseases, from borderline malignant tumors to
carcinomas, there are currently few studies about the long-
term oncologic outcomes after LPD. Palanivelu et al13 re-
ported that the median survival for 42 patients undergoing
LPD was 46 months; the 5-year survival rate was 19.1% for
pancreatic head cancer and 30.7% for ampullary cancer.
3.1.6. Meta-analyses of LPD
Table 1 summarizes eight meta-analyses about LPD.4,6,14e19
All these articles concluded that LPD, which includes hand-
and robot-assisted procedures, is feasible in well-selected
patients who are treated at appropriate high-volume cen-
ters; however, the researchers also indicated that there
were selection and experimenter biases in their
articles.4,6,14e19 Therefore, it is important that more
convincing evaluations of LPD be presented through well-
designed RCTs or prospective cohort studies.
3.2. LDP
3.2.1. Overview of LDP
Distal pancreatectomy is relatively suitable as a laparo-
scopic procedure because, in principle, it does not neces-
sitate reconstruction. LDP was first reported in 1996 by
Gagner et al20 and Cuschieri et al21 and has since become
common as a treatment method for not only benign tumors,
but also pancreatic ductal adenocarcinoma (PDAC) due to
the development of the relevant surgical instruments and
techniques.
LDP may be performed with or without splenic preser-
vation. The main advantage of splenic preservation is that
it avoids the risk of overwhelming postsplenectomy infec-
tion (OPSI), which has an annual incidence of 0.23e0.42%
per year and a lifetime risk of 5%.22 LDP with preservation
of the spleen is usually conducted for benign diagnoses as
the need for lymph node retrieval is not crucial.1 There are
two LDP procedures: one preserves the splenic vasculature
by dissecting the pancreatic parenchyma, and the otherPlease cite this article in press as: Umemura A, et al., Current status
Asian Journal of Surgery (2016), http://dx.doi.org/10.1016/j.asjsur.20divides the splenic artery and vein while preserving the
blood supply to the spleen from the short gastric vessels
(Warshaw technique).23 Long-term prospective studies
about OPSI are however lacking, and LDP with splenic
preservation is considered to be better for benign diseases
to minimize the effect of encapsulated organisms on the
immune system.1
Based on these parameters, there are currently 11 meta-
analyses and good review articles concerning LDP.24e34 All
these articles concluded that LDP is safe, feasible, and
associated with less blood loss, fewer overall complica-
tions, a shorter time to oral intake, and a shorter post-
operative hospital stay compared with open distal
pancreatectomy (ODP).
3.2.2. Meta-analyses and review articles concerning LDP
Table 2 summarizes the 11 meta-analyses and review arti-
cles concerning LDP.19e29 These articles coincide with each
other regarding the similarity of LDP in terms of post-
operative outcomes, hospital stay, and transfusion rate.26,27
However, the superiority of POPF is controversial.26,27,31 In
recent years, LDP has been routinely performed for PDAC,
but its safety and efficacy are still under debate, especially
the R0 resection rate and long-term survival outcome. Ricci
et al33 reported in their meta-analysis that the R0 resection
rates of LDP and ODP were similar (86.3% vs. 80.7%,
ORZ 1.29, 95% CIZ 0.59e2.82, pZ 0.53), and therewas no
statistical difference regarding the number of harvested
lymph nodes (12.9% vs. 12.8%, ORZ0.63, 95%
CIZ1.91e0.65, pZ 0.33). Finally, no difference was
found in terms of overall survival (ORZ 0.66, 95%
CIZ 0.29e1.51, pZ 0.32).33 Sulpice et al34 also reported
that the median survival rates after LDP and ODP for PDAC
were 62.5months and 36.7months, respectively (p< 0.001).
Their multivariate analysis further revealed that LDP was an
independent predictor of survival.34
LDP is no longer an exploratory procedure for a limited
number of surgeons. Therefore, adequately powered and
well-designed RCTs are warranted to establish strong sci-
entific evidence regarding the oncologic outcomes of LDP
for PDAC, including the long-term outcomes.35
3.3. LCP
3.3.1. Overview of LCP
Open central pancreatectomy (OCP) is an alternative
technique for benign or low-grade malignant tumors of the
neck of the pancreas.36 This pancreas-sparing procedure
was developed to maintain exocrine and endocrine func-
tion whose loss could be detrimental to the patient’s
quality of life, and the surgical resection of these tumors
can thus result in a long-term survival.37 On the other hand,
OCP may cause complications, especially POPF, because
central pancreatectomy generates two cut surfaces at the
parenchymal resection site and also requires tight closure
of the main pancreatic duct and parenchyma at the prox-
imal side and appropriate pancreatoenterostomy at the
distal side.38 When pancreatoenterostomy is performed
during LCP, surgeons can select either pancreatogas-
trostomy or Roux-en-Y pancreatojejunostomy. Compared
with OCP, some expert pancreatic surgeons encourage theof laparoscopic pancreaticoduodenectomy and pancreatectomy,
16.09.003
Table 1 Meta-analyses of LPD.
Authors and
Reference
Y No. of
studies
No. of patients
LPD vs. OPD
Surgical
technique
Operative time (min)
LPD vs. OPD
OR/WMD, 95% CI, p
Blood loss (mL)
LPD vs. OPD
OR/WMD, 95% CI, p
POPF (%)
LPD vs. OPD
OR/WMD,
95% CI, p
Hospital stay (d)
LPD vs. OPD
OR/WMD,
95% CI, p
Conclusion
Ammori and
Ayiomamitis14
2011 14 126 only LPD Including HA 448.3 only LPD mean 324.7 only LPD mean 11.6 only LPD 16 Safe and feasible
Strijker et al15 2013 8 131 only LPD Including RA 510 107 only
LPD mean SD
440 254 only
LPD mean SD
26.0 only LPD 15.9 16.7 only
LPD mean SD
Safe and feasible
in selected patients.
Zhang et al16 2013 7 137 vs. 203 Only RA ND ND ND
RRZ 0.61,
0.33e1.14, 0.12
ND Showed potential
of RA procedure
Cirocchi et al17 2013 13 207 vs. 144 Only RA 532.4 vs. 398.1
ND
ND ND 13.2 vs. 19.3
ND
Safe and feasible
Correa-Gallego
et al18
2014 6 169 vs. 373 Including RA ND
131, 43e218, 0.003
ND
1460, 2194
to 726, <0.001
ND
1.11, 0.68e1.83,
0.67
ND
3.7, 6.8
to 0.5, 0.02
Safe and feasible
Lei et al19 2014 9 209 vs. 429 Including
LA, RA
ND
101.66, 27.77e175.55,
<0.001
ND
406.16, 700.05
to 112.28, <0.001
ND
1.12, 0.73e1.73,
0.61
ND
4.14, 7.66
to 0.63, 0.02
Safe and feasible
Qin et al4 2014 11 235 vs. 634 Including RA ND
105, 49.73e160.26,
< 0.001
ND
361.93, 519.22
to 204.63, <0.001
ND
0.96, 0.65e1.44,
0.86
ND
2.64, 4.23
to 1.05, 0.001
Safe and feasible
Boggi et al6 2015 25 746 only LPD Including
HA, RA
464.3 only LPD WA 302.7 only LPD WA 22.3 only LPD WA 13.6 only LPD WA Safe and feasible
CIZ confidence interval; HAZ hand-assisted; LAZ laparoscopy-assisted; LPDZ laparoscopic pancreaticoduodenectomy; NDZ not described; OPDZ open distal pancreatectomy;
ORZODDS RATIO; POPFZ postoperative pancreatic fistula; RAZ robot-assisted; RRZ risk ratio; SDZ standard deviation; WAZweighted average; WMDZ weighted mean difference.
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Table 2 Meta-analyses and good reviews of LDP.
Authors and
Reference
Y No. of
studies
No. of patients
LDP vs. ODP
Surgical
technique
Operative time (min)
LDP vs. ODP
OR/WMD, 95 % CI, p
Blood loss (mL)
LDP vs. ODP
OR/WMD, 95 % CI, p
POPF (%)
LDP vs. ODP
OR/WMD, 95 % CI, p
Hospital stay (d)
LDP vs. ODP
OR/WMD, 95 % CI, p
Conclusion
Giuseppe et al24 2011 10 349 vs. 380 Including
HA, SP
241.48 vs. 217.18, ND
19.125, 8.183
to 46.434
221.68 vs. 535.43
309.358, 447.232
to 171.484
0.088 vs. 0.095
0.682, 0.544e2.661
10.10 vs. 18.92
12.3, 17.084
to 7.516
Safe and feasible
Xie et al25 2012 9 501 vs. 840 Including SP ND
44.947, 13.857e76.037,
0.005
ND
ND
ND
0.996, 0.663e1.494,
0.983
ND
2.713, 3.799
to 1.628, <0.01
Safe and feasible
High SP rate
Jusoh and
Ammori26
2012 11 503 vs. 588 Including SP 220.4 vs. 208.6, NS 237.4 vs. 562.4,
<0.001
16.1 vs. 19.5, 0.154 9.1 vs. 14.7, <0.001 Safe and feasible
Venkat et al27 2012 18 773 vs. 1041 Including HA ND
10.23, 7.12 to 27.59,
0.25
ND
354.98, 885.52
to 857.52, <0.001
ND
4.05, 5.37
to 2.73, <0.001
ND
4.05, 5.37
to 2.73, <0.001
Safe and feasible
Sui et al28 2012 19 805 vs. 1130 Including SP ND
27.97, 4.01e51.94,
<0.001
ND
273.11, 404.61
to 141.61, <0.001
ND
0.86, 0.66e1.13
ND
3.87, 5.06
to 2.68, <0.001
Safe and feasible
Jin et al29 2012 15 561 vs. 895 Including SP ND
20.27, 15.60
to 56.14, 0.27
ND
273.10, 354.39
to 191.81, <0.001
ND
0.82, 0.38e1.78,
0.62
ND
3.65, 5.44
to 1.87, <0.001
Safe and feasible
Ricci et al30 2014 5 125 only LDP
High volume
center vs. low
volume center
Including SP 215.0 vs. 214.0
1.00, 21.33
to 23.23, 0.93
ND 27.4 vs. 26.7
1.04, 0.41e2.62,
0.94
7.5 vs. 11.3
3.80, 15.57
to 2.03, <0.001
Safe and feasible
Mehrabi et al31 2015 23 1328 vs. 1368 Including SP ND
8.88, 1.95
to 19.71, 0.11
ND ND
1.11, 0.85e1.44,
0.46
ND
4.63, 8.21e
1.05, 0.01
Safe and feasible
Yu et al32 2015 10 669 only LDP
SVP vs. WT
440 vs. 259
SP only 348 vs. 171
24.54, 13.56e35.52,
<0.001
328 vs. 170
47.98, 77.26
to 173.22, 0.45
19.4 vs. 19.7
0.77, 0.49e1.22,
0.27
ND There is no significant
difference between
SVP and WT during
LDP with SP
Ricci et al33 2015 5 80 vs. 181
Only PDAC
With
splenectomy
289.9 vs. 237.3
23.42, 13.06e33.79,
<0.001
335.1 vs. 611.0
231.22, 261.74
to 200.69, <0.001
19.3 vs. 21.6
0.75, 0.33e1.71,
0.27
8.2 vs. 13.1
3.03, 4.44
to 1.62, <0.001
LDP for PDAC seems
to be safe and
efficacious
Laurent et al34 2015 d 347 vs. 2406
Only PDAC
Including SP ND ND ND 14.9 vs. 19.6
0.96, 0.94e0.97,
<0.001
LDP is an independent
prognostic factor.
CIZ confidence interval; HAZ hand-assisted; LDPZ laparoscopic distal pancreatectomy; NDZ not described; ODPZ open distal pancreatectomy; ORZ odds ratio; PDACZ pancreatic
ductal adenocarcinoma; POPFZ postoperative pancreatic fistula; SPZ spleen-preserving; SVPZ splenic vessel preservation; WMDZweighted mean difference; WTZWarshaw’s
technique.
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+ MODELuse of LCP for benign or low-grade malignant tumors
because it is minimally invasive with cosmetic advantages
and less perioperative bleeding, allowing for earlier re-
covery and discharge after surgery.
3.3.2. Indications for LCP
Basically, the indications for LCP are the same as those for
OCP.36 The main indication for LCP is benign or low-grade
malignant tumors of the neck of the pancreas, including
neuroendocrine tumors of branch-type IPMN. In addition,
isolated metastatic cancer of the pancreas, especially from
renal cell carcinoma, is also an indication for LCP because
concomitant lymphadenectomy is not necessary.39
3.3.3. Intraoperative outcomes
Machado et al40 have well reported regarding 51 cases of
LCP. In this review, two patients required conversion to
OCP; one because of the loss of a specimen and the other
because of the need for laparotomy when the main
pancreatic duct could not be located.
In line with the reconstruction of the pancreatic
remnant, pancreatogastrostomy and pancreatojejunostomy
were performed in 35.3% and 62.7% of the cases, respec-
tively. The mean operative time was 356.0 minutes, and the
intraoperative blood loss varied from 50 mL to 600 mL.40
On the other hand, there has been only one comparative
study of LCP and OCP, which was conducted by Song et al.41
They compared 26 cases of LCP and 14 cases of OCP with
lesions in the neck and proximal body of the pancreas; the
mean operative times for LCP and OCP were 350.2 minutes
and 270.3 minutes, respectively (pZ 0.001), and the
intraoperative blood loss was 477.1 mL and 555.5 mL for
LCP and OCP, respectively (pZ 0.516).41
3.3.4. Postoperative outcomes
Although the postoperative mortality was nil in the former
articles,40,41 morbidity was quite high, mainly because of
POPF (46%).40 In a retrospective comparative study, there
was no significant difference between LCP and OCP in the
POPF rate (19.2% vs. 35.7%, pZ 0.251).41
The average length of hospital stay was reported as 13.8
days, whereas the range of hospital stay was from 3 days to
41 days.40 Song et al41 also reported that the mean post-
operative hospital stay was significantly longer in the pa-
tients who underwent OCP than in those who underwent
LCP (13.8 days vs. 22.4 days, pZ 0.008).
LCP can be a feasible and useful technique and can lead
to earlier postoperative recovery than OCP. However,
strong evidence of the superiority of LCP in RCTs is still
lacking; therefore, prospective clinical trials comparing
LCP and OCP are warranted.
3.3.5. Oncologic outcomes and endocrine and/or
exocrine insufficiency
All 51 patients underwent LCP for previously described in-
dications: 15 patients were operated on for serous cys-
tadenomas, 13 for neuroendocrine tumors, 7 for mucinous
neoplasms, 6 for solid pseudopapillary tumors, 4 for IPMNs,
and the remaining patients did not show neoplastic in-
dications.40 The average follow-up period was 19.6 months,
and no patients showed exocrine and endocrine pancreatic
insufficiency.Please cite this article in press as: Umemura A, et al., Current status
Asian Journal of Surgery (2016), http://dx.doi.org/10.1016/j.asjsur.20It stands to reason that LCP must not be performed for
obviously malignant pancreatic tumors, including PDAC;
therefore, long-term oncologic survival seems to be
feasible. In addition, extended DP for benign or low-grade
malignant tumors of the neck of the pancreas sacrifices a
normal pancreatic parenchyma to ensure easy resection;
therefore, LCP should be encouraged to avoid the devel-
opment of endocrine and/or exocrine insufficiency.
3.4. LTP
3.4.1. Overview of LTP
Total pancreatectomy usually combines the operative steps
of DP and pancreaticoduodenectomy, but facilitates
reconstruction and has a lower risk of common complica-
tions because it consequently avoids the need for pancre-
atic anastomosis.42e44 On the other hand, severe dyspepsia
and troublesome hyperglycemia occur occasionally due to
the complete exocrine and endocrine function of the
pancreas, and an OPSI, typically characterized by either
meningitis or sepsis caused by encapsulated organisms
(including Streptococcus pneumoniae), can be encountered
if no preoperative vaccination for S. pneumoniae is pro-
vided.22 Based on the need for these operative techniques
and perioperative treatments, open total pancreatectomy
(OTP) has been performed for a limited selection of
patients.45
There were only 21 patients who had undergone LTP,
including robotic or hand-assisted surgery.42e48 It follows
that there have been no prospective clinical studies
comparing LTP and OTP, except for one retrospective case-
matched study.48
3.4.2. Literature review of LTP
The 21 published cases of LTP are summarized in
Table 3.42e48 The usual indications for LTP include multi-
focal pancreatic neuroendocrine tumors (PNET), diffuse
IPMN, metastatic cancer to the pancreas, especially from
renal cell carcinoma, and multiple endocrine neoplasia
Type 1 syndrome.42e45 During open surgery, the decision to
perform OTP is sometimes made intraoperatively for PDAC
with persistent positive margins in frozen sections or in the
case of a fragile pancreatic stump with an unacceptable
anastomotic risk. However, it is quite difficult to achieve a
negative margin of the cut surface laparoscopically in an
additional pancreatic parenchymal transection, and
therefore, surgeons have to carefully choose either LPD or
LTP, considering the tumor location and its progression.
Patients with chronic pancreatitis with refractory pain who
require a total pancreatectomy followed by islet trans-
plantation may be good candidates for LTP.48 The preop-
erative diagnoses of the 21 cases were 15 cases of IPMN, 3
cases of PDAC, 2 cases of PNET, and 1 case of chronic
pancreatitis.
In terms of surgical technique, most of the initial chal-
lenges of LTP were supported by a hand-assisted technique,
especially in the event of splenectomy and reconstruc-
tion.42,43,46 In 2013, Dallemagne et al45 reported the first
two cases of pure LTP that included spleen preservation.
Sunagawa et al47 also described the first laparoscopic total
remnant pancreatectomy after LPD. Additionally, Boggiof laparoscopic pancreaticoduodenectomy and pancreatectomy,
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Table 3 Published cases of LTP and clinical status.
Author and
Reference
Y No. of
patients
Age Sex Surgical
technique
Diagnosis Operative
time (min)
Blood
loss (mL)
Hospital
stay (d)
Complication
Casadei et al42 2009 1 75 Male HA IPMN 485 1200 14 None
Kitasato et al43 2011 1 72 Male HA IPMN 779 1300 78 DGE
Choi et ai44 2012 3 74
69
55
Female
Male
Female
LA
LA
LA
IPMN
IPMN
IPMN
450
410
410
800
160
490
22
17
21
Ulcer
None
None
Dallemagne et al45 2013 2 69
31
Female
Female
LTP
PSPTP
IPMN
PNET
420
360
200
600
8
8
None
None
Dokmak et al46 2014 2 ND
ND
ND
ND
HA IPMN
PNET
270
360
200
300
12
18
Anastomotic
bleeding
Sunagawa et al47 2014 1 72 Female History
of LPD
LTRP
PDAC 462 1200 14 None
Boggi et al48 2014 11 61.8 Male: 6
Female: 5
RA IPMN: 8
PDAC: 2
Pancreatitis: 1
600 220 27 Fluid
collection
Bleeding
Sum/Mean d 21 64.3 M9/F10 d d 455.1 606.4 21.7 d
DGEZ delayed gastric emptying; HAZ hand-assisted; IPMNZ intraductal papillary mucinous neoplasm; LAZ laparoscopy-assisted;
LPDZ laparoscopic pancreaticoduodenectomy; LTPZ laparoscpic total pancreatectomy; LTRPZ laparoscopic total remnant pancrea-
tectomy; NDZ not described; PNETZ pancreatic neuroendocrine tumor; PSPTPZ pyrolus- and spleen-preserving total pancreatec-
tomy; RAZ robot-assisted.
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+ MODELet al48 reported a case-matched study of LTP with a robotic
technique versus OTP.
The intraoperative and postoperative outcomes are also
given in Table 3.42e48 The mean operative time and the
mean blood loss were 455.1 minutes and 606.4 mL,
respectively. Boggi et al48 reported that LTP with a robotic
technique was associated with a longer operative time
(600 min vs. 469 min, pZ 0.014), but a decreased blood
loss when compared with OTP (220 mL vs. 705 mL,
pZ 0.004). The mean postoperative hospital stay was 21.7
days, and there were no mortalities after LTP.
The feasibility and safety including long-term oncologic
outcomes of LTP have not been demonstrated adequately
due to the lack of surgeon’s experience with LTP and the
absence of well-designed comparative studies between LTP
and OTP. Further experience and comparative studies are
needed to clarify the role of LTP in the management of
selected patients with pancreatic disease, and a final
assessment will only be possible following RCTs.4. Discussion
Currently, MIPS includes totally laparoscopic, laparoscopy-
assisted, hand-assisted, and robot-assisted procedures. As
is the trend for laparoscopic surgery for other organs,
laparoscopy-assisted surgery has been switched to totally
laparoscopic surgery in various pancreatectomies to allow
greater magnification, a wider view, and practical use of
more refined surgical techniques.49 As a new and progres-
sive strategy, MIPS is still in its early stages, and compari-
sons of MIPS and conventional open procedures are rare.1,2
For LPD and LDP, some meta-analyses using the largest
available datasets of published studies have led to defini-
tive conclusions.4,6,23,24 The results of these meta-analysesPlease cite this article in press as: Umemura A, et al., Current status
Asian Journal of Surgery (2016), http://dx.doi.org/10.1016/j.asjsur.20have demonstrated that LPD and LDP are associated with a
decrease in blood loss and wound infection and a shorter
hospital stay. On the other hand, LPD and LDP require a
longer operative time. In terms of POPF, mortality, and
oncologic outcomes, there were no significant differences
in LPD and LDP compared with conventional open proced-
ures. Considering that in most cases the patients received
LPD or LDP owing to pancreatobiliary malignant tumors, a
concise comparison of oncologic safety is important.
Therefore, adequately powered and well-designed RCTs are
required to establish sound conclusions regarding the
oncologic outcomes of LPD for each disease.
Relatively speaking, laparoscopic resection of the neck
of the pancreas or any segment in the middle of the
pancreas is not difficult; however, LCP necessarily entails
reconstruction of the disconnected main pancreatic duct,
which may be difficult and sometimes hazardous lapa-
roscopically. Although extended LDP is popularly performed
for patients who have to undergo LCP to avoid this situa-
tion, this tendency is at the expense of the pancreatic
endocrine and exocrine functions.38 Accordingly, LCP
should only be performed for patients with benign or low-
grade neoplasms. The pancreatic reconstruction in LCP
may entail a Roux-en-Y pancreatojejunostomy or a pan-
creatogastrostomy. Some authors believe that the POPF
rate is lower with pancreatogastrostomy, citing better
blood supply to the anastomosis and the inactivation of the
pancreatic enzymes, with gastric juice preventing the
erosion of the anastomosis, as possible reasons. On the
other hand, Roux-en-Y pancreatojejunostomy is performed
in a duct-to-mucosa method or using the dunking technique
and is thought to have a better long-term outcome.36e38 As
LCP is usually indicated in patients with expected long-term
survival, Roux-en-Y pancreatojejunostomy may be the
best management for the distal remnant pancreas.of laparoscopic pancreaticoduodenectomy and pancreatectomy,
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+ MODELNevertheless, strong evidence via RCTs of the superiority of
LCP is still lacking. It is also unclear that either Roux-en-Y
pancreatojejunostomy or pancreatogastrostomy offers
better reconstruction of the distal remnant pancreas.36e38
In terms of LTP, indications such as multifocal PNET,
diffuse IPMN, and metastatic cancer to the pancreas are
scarce; however, LTP needs to be carefully considered
against the potential risk of the postoperative problems
derived from the complete loss of pancreatic exocrine and
endocrine function.44,45 There are two possible procedures:
total spleno-pancreatectomy (TSP) and pylorus- and spleen-
preserving total pancreatectomy (PSPTP). TSP is under-
taken for malignant tumors, particularly for diffuse IPMN,
because it is necessary to harvest the lymph nodes at the
hilum of the spleen. On the other hand, PSPTP is an organ-
and function-preserving procedure and is therefore indi-
cated for borderline malignant tumors. PSPTP combines the
pylorus-preserving technique with the metabolic, immuno-
logical function of the spleen and their impact on the
postoperative complications of splenectomy. That said, not
only open but also laparoscopic PSPTP may be associated
with longer operative times and higher blood loss compared
with TSP.44,45 At this time, the clinical advantages of LTP
have not been clearly demonstrated owing to the low
number of patients undergoing LTP. Therefore, well-skilled
laparoscopic surgeons should encourage the use of LTP for
suitable indicated patients to demonstrate the safety and
feasibility of LTP. Subsequently, comparative studies will be
needed to clarify the role of LTP in the management of
selected patients with pancreatic disease, and a final
assessment using RCTs will eventually become necessary.
In this review, we have described recent advances in
MIPS. Recently, many articles have shown that LPD and LDP
are safe and may result in improved perioperative recovery
and an equivalent oncologic outcome compared with OPD
and ODP; however, all these studies about LPD and LDP are
retrospective. Therefore, adequately powered and well-
designed RCTs are warranted to draw firm conclusions
about the short-term and long-term oncologic outcomes of
LPD and LDP.
On the other hand, LCP and LTP are not accepted as
standard procedures because of the demanding advanced
laparoscopic techniques and the lack of appropriate pa-
tients. Further retrospective studies as well as RCTs con-
cerning LCP and LTP are required to demonstrate their
safety and feasibility for patients with selected pancreatic
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